kk jili 777
A Nigerian lady did what pissed her husband off, and she decided to apologise to him through a long text message Adem and Ayomi made a post on TikTok showing netizens their funny banter after they had a quarrel The wife said she had snapped at her husband in the morning before he went to work and she had to apologise CHECK OUT: Education is Your Right! Don’t Let Social Norms Hold You Back. Learn Online with LEGIT. Enroll Now! A text message a Nigerian woman sent to her husband is trending online after it was posted on TikTok . Adem and Ayomi posted a text message that shows how the woman begged her husband for forgiveness. According to the lady, she had offended her husband before he left home for work in the morning. She decided to send him a text message to ask for his forgiveness while he was still at work. PAY ATTENTION: Legit.ng Needs Your Help! Take our Survey Now and See Improvements at LEGIT.NG Tomorrow She said in the message: "My love, my king, I am so sorry for snapping out on you this morning, I am sorry if I am not respecting you enough, and I am sorry if I am not appreciating you enough. I am deeply sorry for every other way I have always wronged you. Forgive me, baby. I LOVE YOU FOREVER." Read also Pastor Jerry Eze shares how he handled a woman that once beat up his late mum: "Forgiveness is hard" In response, her husband said: "Mumu, who teach you English (Snapping) It's okay babe I love you more." See reactions from netizens below: @ThatBlackboy said: "Once my babe apologizes I automatically turn weak man, my head go con dey swell, in fact na that time I dey love her pass, transfer left and right." @MO said: "Matured man. Not all these immature boys that are always forming hard to get even after apologizing when you are not wrong...But just for the sake of peace." @Boss—lady said: "Someone should pls teach me how to apologize again .... Someone else is paying for what my ex turns me to." Lady and husband do NYSC in the location Meanwhile, a Nigerian lady and her husband, who are both graduates , were posted to the same NYSC orientation camp. The lady shared a video showing how they had fun during the NYSC camping period, which lasted three weeks. Read also "My first and only boyfriend": Lady celebrates being together with only one man since 2017 The video went viral and got many comments from social media users, some of whom said they were seeing such a coincidence for the first time. PAY ATTENTION: Сheck out news that is picked exactly for YOU ➡️ find the “Recommended for you” block on the home page and enjoy! Source: Legit.ng
Shivalik Bimetal Controls: Seeing light from sunrise sectors
Jacob Bethell will bat at No 3 on his England Test debut against New Zealand - just days after being picked up in the IPL auction for £250,000 - as Ollie Pope moves down the order Jacob Bethell will bat at No 3 on his England Test debut against New Zealand The 21-year-old made his ODI and T20 debuts just two months ago in September By LAWRENCE BOOTH Published: 22:40 GMT, 25 November 2024 | Updated: 22:40 GMT, 25 November 2024 e-mail View comments Jacob Bethell will bat at No 3 on his Test debut in Christchurch on Wednesday night after England were forced to rejig their plans following Jordan Cox’s broken thumb. The move means Ollie Pope – who will take the gloves for the first time in two years – will drop down three places to No 6, while captain Ben Stokes comes in at No 7. The 21-year-old Bethell has never batted at No 3 in his 20 first-class games for Warwickshire, which have produced a modest 738 runs at an average of 25. And he has batted at No 4 only twice. He will also be the first specialist batter to play Test cricket for England without a first-class hundred under his belt since Mike Gatting in 1978. The news completes a heady couple of days for Bethell, after he was picked up in the IPL auction by Royal Challengers Bangalore for just under £250,000. And it means he will have made his international debut in all three formats in less than three months, after breaking into the white-ball sides against Australia in September. For Pope, who last kept wicket in a Test at Multan in December 2022, the rejig spares him further scrutiny at No 3, where he has reached 30 only once in his last 12 Test innings. Jacob Bethell will bat at No 3 on his Test debut in Christchurch on Wednesday night Bethell made his T20 debut on September 11 this year and his ODI debut just eight days later Stokes, meanwhile, could be liberated by his move to No 7, after struggling for runs on his return to the Test side from injury in Pakistan. He will be one of four seamers in the side, along with Chris Woakes, Gus Atkinson and Brydon Carse, with Shoaib Bashir the lone frontline spinner on a Hagley Oval surface that looked green 48 hours out from the start of the three-match series. England for first Test v New Zealand 1 Zak Crawley, 2 Ben Duckett, 3. Jacob Bethell, 4 Joe Root, 5 Harry Brook, 6 Ollie Pope (wkt), 7 Ben Stokes (capt), 8 Chris Woakes, 9 Gus Atkinson, 10 Brydon Carse, 11 Shoaib Bashir. New Zealand Ben Stokes Share or comment on this article: Jacob Bethell will bat at No 3 on his England Test debut against New Zealand - just days after being picked up in the IPL auction for £250,000 - as Ollie Pope moves down the order e-mail Add comment
( MENAFN - GlobeNewsWire - Nasdaq) MELBOURNE, Australia and INDIANAPOLIS, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) today announces that it has submitted its Biologics License Application (BLA) to the United States (U.S.) Food and Drug Administration (FDA) for TLX250-CDx (Zircaix®1, 89Zr- girentuximab) kidney cancer imaging2. TLX250-CDx is an investigational PET3 drug product for the non-invasive diagnosis and characterization of clear cell renal cell carcinoma (ccRCC), the most common and aggressive form of kidney cancer. If approved, TLX250-CDx will be the first and only targeted PET agent specifically for kidney cancer to be commercially available in the U.S., further building on Telix's successful urology imaging franchise. The FDA is expected to advise the PDUFA4 goal date following the 60-day administrative review of the application. Kevin Richardson, Chief Executive Officer, Precision Medicine at Telix, stated,“We are pleased to be progressing the BLA for TLX250-CDx, which has been granted Breakthrough designation, and may therefore be eligible for priority review. Telix continues to target a full U.S. commercial launch in 2025 addressing a major unmet medical need for patients with suspected ccRCC.” About TLX250-CDx TLX250-CDx (Zircaix®1) is an investigational PET agent that is under development for the diagnosis and characterization of ccRCC. Telix's pivotal Phase III ZIRCON trial (ClinicalTrials.gov ID: NCT03849118 ) evaluating TLX250-CDx in 300 patients, of whom 284 were evaluable, met all primary and secondary endpoints, including showing 86% sensitivity and 87% specificity and a 93% positive-predictive value for ccRCC across three independent radiology readers5. Telix believes this demonstrated the ability of TLX250-CDx to reliably detect the clear cell phenotype and provide an accurate, non-invasive method for diagnosing and characterizing ccRCC. Confidence intervals exceeded expectations amongst all three readers, showing evidence of high accuracy and consistency of interpretation. About Telix Pharmaceuticals Limited Telix is a biopharmaceutical company focused on the development and commercialization of diagnostic and therapeutic radiopharmaceuticals and associated medical technologies. Telix is headquartered in Melbourne, Australia, with international operations in the United States, Europe (Belgium and Switzerland), and Japan. Telix is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX: TLX) and the Nasdaq Global Select Market (Nasdaq: TLX). Telix's lead imaging product, gallium-68 (68Ga) gozetotide injection (also known as 68Ga PSMA-11 and marketed under the brand name Illuccix®), has been approved by the U.S. Food and Drug Administration (FDA)6, by the Australian Therapeutic Goods Administration (TGA) 7, and by Health Canada8. No other Telix product has received a marketing authorization in any jurisdiction. Visit for further information about Telix, including details of the latest share price, announcements made to the ASX, investor and analyst presentations, news releases, event details and other publications that may be of interest. You can also follow Telix on X and LinkedIn . Telix Investor Relations Ms. Kyahn Williamson Telix Pharmaceuticals Limited SVP Investor Relations and Corporate Communications Email: ... This announcement has been authorised for release by the Telix Pharmaceuticals Limited Disclosure Committee on behalf of the Board. Legal Notices You should read this announcement together with our risk factors, as disclosed in our most recently filed reports with the Australian Securities Exchange (ASX), U.S. Securities and Exchange Commission (SEC), including our registration statement on Form 20-F filed with the SEC, or on our website. The information contained in this announcement is not intended to be an offer for subscription, invitation or recommendation with respect to securities of Telix Pharmaceuticals Limited (Telix) in any jurisdiction, including the United States. The information and opinions contained in this announcement are subject to change without notification. To the maximum extent permitted by law, Telix disclaims any obligation or undertaking to update or revise any information or opinions contained in this announcement, including any forward-looking statements (as referred to below), whether as a result of new information, future developments, a change in expectations or assumptions, or otherwise. No representation or warranty, express or implied, is made in relation to the accuracy or completeness of the information contained or opinions expressed in the course of this announcement. This announcement may contain forward-looking statements, including within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that relate to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as“may”,“expect”,“intend”,“plan”,“estimate”,“anticipate”,“believe”,“outlook”,“forecast” and“guidance”, or the negative of these words or other similar terms or expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on Telix's good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect Telix's business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context of Telix's business, forward-looking statements may include, but are not limited to, statements about: the initiation, timing, progress and results of Telix's preclinical and clinical trials, and Telix's research and development programs; Telix's ability to advance product candidates into, enrol and successfully complete, clinical studies, including multi-national clinical trials; the timing or likelihood of regulatory filings and approvals for Telix's product candidates, manufacturing activities and product marketing activities; Telix's sales, marketing and distribution and manufacturing capabilities and strategies; the commercialisation of Telix's product candidates, if or when they have been approved; Telix's ability to obtain an adequate supply of raw materials at reasonable costs for its products and product candidates; estimates of Telix's expenses, future revenues and capital requirements; Telix's financial performance; developments relating to Telix's competitors and industry; and the pricing and reimbursement of Telix's product candidates, if and after they have been approved. Telix's actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements. ©2024 Telix Pharmaceuticals Limited. The Telix Pharmaceuticals®, Illuccix® and Zircaix®1 names and logos are trademarks of Telix Pharmaceuticals Limited and its affiliates – all rights reserved. 1 Brand name subject to final regulatory approval. 2 Telix ASX disclosure 31 July 2024. The FDA requested additional data demonstrating adequate sterility assurance during dispensing of TLX250-CDx in the radiopharmacy production environment. 3 Positron emission tomography. 4 Prescription Drug User Fee Act. 5 Shuch et al. Lancet Oncol. 2024. Telix ASX disclosures 7 November 2022. 6 Telix ASX disclosure 20 December 2021. 7 Telix ASX disclosure 2 November 2021. 8 Telix ASX disclosure 14 October 2022. MENAFN29122024004107003653ID1109039937 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
WINSTON-SALEM, N.C. (AP) — It wasn’t how Duke drew up the final play, but it worked out perfect for the Blue Devils in Saturday’s 23-17 victory over Wake Forest. Maalik Murphy threw a 39-yard touchdown pass to Jordan Moore as time expired, allowing Duke to end the regular season with three consecutive victories. Murphy said he realized he took too long to make a decision after the last snap. “I knew at that point I had to make a play,” he said. “The damage was already done, time was ticking.” With the score tied at 17, the Blue Devils (9-3, 5-3 Atlantic Coast Conference) moved 76 yards in 1:22 after forcing a Wake Forest punt. It appeared that Duke might run out of time in the slow-developing play, but Moore improvised and broke free along the right side, caught the ball at the 10-yard line and spun into the end zone to complete a comeback from 14 points down in the second half. “The play that Maalik and Jordan put together was magical,” Duke coach Manny Diaz said. “Nobody thought a 5-yard route would turn into a (long) touchdown.” So instead of a long field-goal attempt, Duke had something better. “I just decided to take it down the field,” Moore said. “I think that’s a testament to our chemistry. ... Maalik had the confidence in himself to make that kind of play.” It resulted in Duke’s sixth victory by seven points or less. “It’s like a perfect exclamation point to our season,” Diaz said. “An unbelievable way to finish our season.” Murphy racked up with 235 yards on 26-for-34 passing. Moore, who was down with an injury after a reception earlier in the second half, made five catches for 98 yards. Hank Bachmeier threw for 207 yards and a touchdown as Wake Forest (4-8, 2-6) ended its second straight four-win season with a four-game losing streak. “A heartbreaking loss,” Demon Deacons coach Dave Clawson said. “It’s a tough way to lose a game and a tough way to end the season.” Tate Carey’s 8-yard run, Matthew Dennis’ 37-yard field goal and Horatio Fields’ 9-yard reception across 11 minutes of game time gave Wake Forest a 17-3 lead with nine minutes left in the third quarter. Duke took advantage of a short field following a punt, moving 42 yards in four plays to score on Star Thomas’ 3-yard run. The Blue Devils recovered a fumble on the ensuing kickoff and converted on Murphy’s 2-yard run with 12:57 left to pull even. “What has been proven is that we’re mentally tough,” Diaz said. “We’re not going to do everything perfect.” Taylor Morin became Wake Forest’s all-time leader in receiving yards with 2,974. He picked up 47 yards on eight catches on Saturday. Morin, in his fifth season, passed former NFL player Ricky Proehl, who had 2,929 yards in the late 1980s. Duke: The Blue Devils have secured at least a nine-win season for the second time in three seasons, this one coming in Diaz’s first season. They racked up a 4-0 record against in-state opponents, including comebacks to top North Carolina and Wake Forest. “Every quest that we have for championships starts in our own state,” Diaz said. Wake Forest: The Demon Deacons punted on their final three possessions of the season. They finished with a 1-6 record in home games. “It’s been a tough year, a long year, and I’m proud of our team and how hard they fought,” Clawson said. Duke: Awaits a bowl invitation Wake Forest: Enters the offseason with a losing record for the third time in five seasons. Get poll alerts and updates on the AP Top 25 throughout the season. Sign up here . AP college football: https://apnews.com/hub/ap-top-25-college-football-poll and https://apnews.com/hub/college-footballNoneLucknow: Sixty-eight villages in Uttar Pradesh, each with a population of less than 500 and located in aspirational blocks , will soon be connected through a rural road network under the PM Gramin Sadak Yojana (PMGSY). The ambitious project, aimed at expediting rural connectivity in the state, is proposed to be undertaken under the fourth phase of the PMGSY, which will continue until the 2028-29 fiscal year. Of the 500 aspirational blocks identified by NITI Aayog, Uttar Pradesh accounts for the highest number at 68, followed by Bihar with 61. The 68 aspirational blocks also include those in eight aspirational districts: Bahraich, Balrampur, Chandauli, Chitrakoot, Shravasti, Siddharthnagar, Sonbhadra, and Fatehpur. PMGSY-4 entails financial assistance for the construction of 62,500 km of all-weather roads in 25,000 unconnected habitations across 500 aspirational blocks nationwide. The total outlay for this scheme is estimated at over Rs 70,000 crore. A senior UPRRDA official said that the all-weather roads would play a crucial role in catalysing the socio-economic development and transformation of remote rural areas. PMGSY-4 will incorporate international benchmarks and best practices in road construction, such as cold mix technology, waste plastic, panelled cement concrete, cell-filled concrete, full depth reclamation, and the use of construction waste and other materials like fly ash and steel slag, according to a press note from the Centre. Stay updated with the latest news on Times of India . Don't miss yearly career horoscopes 2025 for Aries , Taurus , Gemini , Cancer , Leo , Virgo , Libra , Scorpio , Sagittarius , Capricorn , Aquarius , and Pisces .
The Fall of Ant Group's IPO: Alibaba's Missteps, Legal Battles, and a $433.5M SettlementThe last thing the San Francisco 49ers needed for their Week 12 matchup with the Green Bay Packers was to be without their starting quarterback, but it appears they may have to deal with that scenario. Brock Purdy left practice on Thursday after throwing just a few passes in the section of the session open to media. According to Matt Maiocco of NBC Sports Bay Area , Purdy was seen getting his shoulder rubbed by head athletic trainer Dustin Little before the quarterback left prior to the start of practice. Purdy has been dealing with shoulder soreness in the wake of the 49ers' surprise loss to the Seattle Seahawks last Sunday, one which left them 5-5 and bottom of the NFC West. He was officially listed as limited for Thursday's session, but the 49ers' decision to push the usual quarterback media session back to Friday suggested there is a strong chance Purdy will not play at Lambeau Field. If that proves to be the case, Brandon Allen would get the start under center for the 49ers. Joshua Dobbs is the third-stringer. Nick Bosa and Trent Williams again missed practice, while reigning Offensive Player of the Year Christian McCaffrey was back after a rest day on Wednesday. Rookie wide receiver Jacob Cowing sat out the session after being limited on Wednesday, indicating he is on course to miss the game with a concussion suffered against Seattle. 49ers injury report This article first appeared on A to Z Sports and was syndicated with permission.
None
Tech review: Gift options for the cord cutter6 Ways to Spot Shovelware Games Without Downloading
9 Things To Buy at Costco This Winter If You Live on Social SecurityChargers will be without top RB Dobbins and could lean on QB Herbert against Falcons
Bumbling jihadi: Mark John Taylor charged under Terrorism Suppression Act, believed to be in Syria – The Front Page